A Clinical Trial Hot Spot: Australia’s Attractions For Korean Firms

Ausbiotech’s CEO and the Senior Trade and Investment Commissioner at the Australian Embassy in South Korea talk to Scrip’s Jung Won Shin on the sidelines of Bio Korea 2022 about what makes Australia an attractive clinical trial destination for Korean and other foreign firms, as well as collaborations and other opportunities between the two countries.